300 related articles for article (PubMed ID: 17404288)
1. Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist.
Waiboci LW; Ahmed CM; Mujtaba MG; Flowers LO; Martin JP; Haider MI; Johnson HM
J Immunol; 2007 Apr; 178(8):5058-68. PubMed ID: 17404288
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function.
Flowers LO; Johnson HM; Mujtaba MG; Ellis MR; Haider SM; Subramaniam PS
J Immunol; 2004 Jun; 172(12):7510-8. PubMed ID: 15187130
[TBL] [Abstract][Full Text] [Related]
3. Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing/remitting form.
Mujtaba MG; Flowers LO; Patel CB; Patel RA; Haider MI; Johnson HM
J Immunol; 2005 Oct; 175(8):5077-86. PubMed ID: 16210611
[TBL] [Abstract][Full Text] [Related]
4. A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells.
Flowers LO; Subramaniam PS; Johnson HM
Oncogene; 2005 Mar; 24(12):2114-20. PubMed ID: 15688010
[TBL] [Abstract][Full Text] [Related]
5. SOCS-1 mimetics protect mice against lethal poxvirus infection: identification of a novel endogenous antiviral system.
Ahmed CM; Dabelic R; Waiboci LW; Jager LD; Heron LL; Johnson HM
J Virol; 2009 Feb; 83(3):1402-15. PubMed ID: 19019946
[TBL] [Abstract][Full Text] [Related]
6. New mimetic peptides of the kinase-inhibitory region (KIR) of SOCS1 through focused peptide libraries.
Doti N; Scognamiglio PL; Madonna S; Scarponi C; Ruvo M; Perretta G; Albanesi C; Marasco D
Biochem J; 2012 Apr; 443(1):231-40. PubMed ID: 22166051
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signaling.
Ahmed CM; Dabelic R; Martin JP; Jager LD; Haider SM; Johnson HM
J Immunol; 2010 Jul; 185(2):1103-13. PubMed ID: 20543109
[TBL] [Abstract][Full Text] [Related]
8. The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis.
Jager LD; Dabelic R; Waiboci LW; Lau K; Haider MS; Ahmed CM; Larkin J; David S; Johnson HM
J Neuroimmunol; 2011 Mar; 232(1-2):108-18. PubMed ID: 21131060
[TBL] [Abstract][Full Text] [Related]
9. Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.
Recio C; Oguiza A; Lazaro I; Mallavia B; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1953-60. PubMed ID: 25012131
[TBL] [Abstract][Full Text] [Related]
10. IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes.
Cho HJ; Kim SK; Jin SM; Hwang EM; Kim YS; Huh K; Mook-Jung I
Glia; 2007 Feb; 55(3):253-62. PubMed ID: 17091494
[TBL] [Abstract][Full Text] [Related]
11. Suppressor of cytokine signaling 1 protects rat pancreatic islets from cytokine-induced apoptosis through Janus kinase/signal transducers and activators of transcription pathway.
Sun Q; Xiang RL; Yang YL; Feng K; Zhang K; Ding WY
Chin Med J (Engl); 2013 Nov; 126(21):4048-53. PubMed ID: 24229672
[TBL] [Abstract][Full Text] [Related]
12. JAK2 and SHP2 reciprocally regulate tyrosine phosphorylation and stability of proapoptotic protein ASK1.
Yu L; Min W; He Y; Qin L; Zhang H; Bennett AM; Chen H
J Biol Chem; 2009 May; 284(20):13481-13488. PubMed ID: 19287004
[TBL] [Abstract][Full Text] [Related]
13. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells.
Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M
Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961
[TBL] [Abstract][Full Text] [Related]
14. The SOCS1 KIR and SH2 domain are both required for suppression of cytokine signaling in vivo.
Doggett K; Keating N; Dehkhoda F; Bidgood GM; Meza Guzman LG; Leong E; Kueh A; Nicola NA; Kershaw NJ; Babon JJ; Alexander WS; Nicholson SE
Cytokine; 2023 May; 165():156167. PubMed ID: 36934508
[TBL] [Abstract][Full Text] [Related]
15. Role of tyrosine 441 of interferon-gamma receptor subunit 1 in SOCS-1-mediated attenuation of STAT1 activation.
Qing Y; Costa-Pereira AP; Watling D; Stark GR
J Biol Chem; 2005 Jan; 280(3):1849-53. PubMed ID: 15522878
[TBL] [Abstract][Full Text] [Related]
16. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities.
Song MM; Shuai K
J Biol Chem; 1998 Dec; 273(52):35056-62. PubMed ID: 9857039
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
Delgado M; Ganea D
J Immunol; 2000 Sep; 165(6):3051-7. PubMed ID: 10975815
[TBL] [Abstract][Full Text] [Related]
18. SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19.
Johnson HM; Lewin AS; Ahmed CM
Front Immunol; 2020; 11():582102. PubMed ID: 33193390
[TBL] [Abstract][Full Text] [Related]
19. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
[TBL] [Abstract][Full Text] [Related]
20. SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function.
Ahmed CM; Larkin J; Johnson HM
Front Immunol; 2015; 6():183. PubMed ID: 25954276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
